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Abstract
Background: Maintaining the therapeutic care of psychiatric patients during the first wave of the COVID-19
pandemic in Switzerland required changes to the way in which sessions were conducted, such as telepsychiatric
interventions or using face masks during on-site sessions. While little is known about how face masks affect the
therapeutic experience of patients and therapists, the effectiveness of telepsychiatry is well documented for several
psychiatric disorders. However, research on the benefits of telepsychiatry in adult patients with attention-deficit/
hyperactivity disorder (ADHD) remains scarce. This seems problematic since the symptoms typically associated with
ADHD, such as attention problems and distractibility, may lessen the utility of telepsychiatry for this particular
group. The present study’s aim was to explore how adult patients with ADHD and their therapists experienced
therapy sessions during the COVID-19 pandemic in three different settings: face-to-face with the therapist wearing a
face mask, via telephone, or via videoconferencing.
Methods: In this exploratory, quantitatively driven mixed-method study (quantitative questionnaire data and
qualitative data from open-ended responses), we assessed patients’ evaluation of the session, their treatment
satisfaction, and patients’ and therapists’ ratings of therapeutic alliance. We also collected qualitative comments on
both sides’ experience of the session. Overall, 97 therapist and 66 patient questionnaires were completed. Results
are reported for the N = 60 cases for which data from both parties were available. Sequential multiple regressions
adjusted for therapist and number of sessions were used for the main quantitative analyses.
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Results: No statistically significant differences regarding session flow, post-session positivity, satisfaction and
therapeutic alliance were observed. The only exception was that telepsychiatric sessions were rated as significantly
less deep than face-to-face sessions, an effect that may decline over time, especially in the videoconferencing
group. Patients and therapists identified similar facilitating and complicating aspects, but differed in their emphasis
of specific elements.
Conclusions: Both settings, on-site with the therapist wearing a face mask and telepsychiatric, seem to be valid
options to continue treatment of adults with ADHD during a situation such as the COVID-19 pandemic. Aspects
such as patient preference, session content, and therapeutic methods may be useful to identify the most suitable
modality.
Keywords: COVID-19 pandemic, Attention-deficit/hyperactivity disorder (ADHD), Telepsychiatry, Therapeutic alliance,
Face mask, Face-to-face treatment, Videoconferencing, Telephone, Satisfaction
The first Swiss COVID-19 case was confirmed on the
24th of February 2020 [1]. On the 16th of March, the
Swiss Federal Council declared an ‘extraordinary situ-
ation’ and introduced stringent regulations to slow down
the spread of the virus (COVID-19 Ordinance 2 [2])
during the so-called first wave; citizens were advised to
stay home whenever possible and gatherings of more
than five individuals were prohibited shortly thereafter.
The impact of the COVID-19 pandemic was not con-
fined to people’s working and social lives, however. First
and foremost, it affected their access to health care,
including psychiatric care. Following the declaration of
the ‘extraordinary situation’, medical treatment pro-
viders, including psychiatrists and psychotherapists, were
obliged by the government not to offer treatment that
was not considered to be medically urgent in order to
decelerate the spread of the virus [3]. At the same time,
psychiatrists and psychotherapists had a duty to main-
tain psychiatric and psychotherapeutic care of the Swiss
population by delivering indicated treatment that could
not be delayed (see e.g. [4]).
To cope with this dilemma, both the society of Swiss
psychiatrists – the Foederatio Medicorum Psychiatri-
corum et Psychotherapeuticorum [5] – and the Confed-
eration of Swiss Psychologists [6] recommended that
treatment via telephone or videoconferencing tools
should be implemented and chosen over face-to-face
sessions. In other words, psychiatrists and psychothera-
pists were advised to resort to telepsychiatric treatment
whenever possible, even though this form of treatment
provision was only partially reimbursed by health in-
surers [7]. If on-site treatment was necessary and un-
avoidable, significant changes to the course of a session
had to be made. Based on the recommendations of the
Federal Office of Public Health and the FMPP [8], the
internal regulations of the outpatient clinic in which the
present study was conducted included: (1) following hy-
giene rules before the session (supervised hand disinfec-
tion and temperature measurement including a check
for symptoms of a possible COVID-19 infection at the
entrance of the building), (2) observing distancing rules
during the session, and (3) the therapist wearing a face
mask during the session.1 Thus, continuing psychiatric
or psychotherapeutic treatment during the COVID-19
pandemic required substantial changes to the way ses-
sions were usually conducted, either by resorting to
telepsychiatry or by making significant adjustments to
on-site sessions including wearing face masks during
therapy sessions.
The use of face masks in face-to-face treatment
While questions relating to the potential effects wearing
face masks might have on therapy sessions and the
therapeutic relationship have been discussed in recent
Letters to the Editor [9–12] and discussion papers [13],
little is known about their actual impact. A randomised
controlled trial from Hong Kong in 2011, which exam-
ined patients’ reaction to their general practitioner wear-
ing a face mask during the consultation, found negative
effects on patients’ perception of the general practi-
tioner’s empathy, an effect that was more pronounced
for more established general practitioner-patient rela-
tionships [14]. We are not aware of a study that has in-
vestigated psychiatric outpatients’ experience of the
session or the therapeutic relationship when the therap-
ist is wearing a face mask.
Telepsychiatry versus face-to-face therapy
A main benefit of telepsychiatry – in this study defined
as synchronous therapeutic interventions that are not
delivered on-site – is often seen in its ability to provide
access to care for patients who, for instance, live in rural
or remote areas (see e.g. [15, 16]). However, the
COVID-19 pandemic highlighted the importance of
1At the time of data collection, wearing face masks during therapy
sessions was not compulsory in Switzerland. However, as of late
March 2020, the outpatient clinic made wearing a face mask
mandatory for staff with direct patient contact to protect the patients.
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telepsychiatry in upholding provision of treatment inde-
pendently of physical location in general. Additional ad-
vantages of telepsychiatry include cost-effectiveness [17],
and, according to the experience of care providers, flex-
ible scheduling and timely starts [18].
Over the past decades, the effectiveness of telepsy-
chiatry has been examined in numerous studies. With
respect to treatment outcome, empirical evidence sug-
gests that telepsychiatry is on a par with face-to-face
treatment for various psychiatric disorders [19], in-
cluding anxiety disorder [20, 21], depression [21], and
post-traumatic stress disorder [22–24]. Also, patients
seem to be as satisfied with tele-mental health inter-
ventions as they are with in-person treatment ([25],
see also e.g. [26]). Some therapists, however, have
expressed concerns that the lack of physical inter-
action in a telepsychiatric setting could hinder the de-
velopment of a healthy therapeutic alliance (TA) (see
e.g. [27]), which is often conceptualised as (1) an
emotional bond between patient and therapist and (2)
collaboration and consensus between the two parties
on the goals and tasks of the therapy [28]. A thor-
ough understanding of the impact of treatment mo-
dality on TA is essential given that TA has been
found to be one of the strongest predictors of treat-
ment outcome in face-to-face psychotherapy [29, 30],
although the specific relevance of TA and its individ-
ual sub-components in telepsychiatric settings still
warrants further investigation [31, 32].
Reviews of the literature suggest that concerns about
TA in telepsychiatry may be unfounded. Patients’ ratings
of TA are fairly comparable for in-person and telepsy-
chiatric interventions. In their review of video therapy
treatment (k = 22), which included patient samples with
a wide range of diagnoses including mixed anxiety and
depression, posttraumatic stress disorder, and obsessive-
compulsive disorders, Simpson and Reid summarised (p.
289): “TA ratings ( …) were surprisingly homogenous
across studies, and roughly equivalent to TA ratings for
in-person therapy in those studies with a comparison
group” [33]. Similarly, in a review on therapy delivered
via telephone (k = 5; diagnoses included in the reviewed
studies were major depressive disorder, non-affective
psychosis and no specified diagnosis), no statistically sig-
nificant difference in TA ratings between the two modal-
ities were reported [34], although results may have been
influenced by the fact that most of the studies included
used non-randomised opportunity samples. Interestingly,
Simpson and Reid [33] reported that therapists did not
rate TA quite as highly as their patients, especially in the
early stages of treatment. Thus, some therapists seemed
– at least initially – slightly more sceptical, whereas pa-
tients appeared to perceive TA similarly across the dif-
ferent treatment modalities.
Attention-deficit/hyperactivity disorder (ADHD)
ADHD is a highly inheritable [35] neuropsychiatric dis-
order [36] characterized by its core symptoms of inatten-
tion, impulsivity and hyperactivity and further accessory
symptoms such as emotional over-reaction and affective
lability [37]. The view of ADHD as a disease of youth
that is outgrown in later life (see e.g. [37]) has had to be
revised over the course of the last few decades. ADHD
may persist either in a form that still meets the full cri-
teria for a diagnosis of ADHD or in the form of clinically
significant impairment associated with residual symp-
toms [38–41], as symptoms of hyperactivity and impul-
sivity generally tend to decrease with age [42]. The
prevalence rate for ADHD up to the age of 18 is esti-
mated at 5.3% [36] and for adult ADHD at 2.5% [43].
While ADHD is still highly prevalent in adulthood, it
is also a severely underdiagnosed condition [44]. As rec-
ommended by the NICE guidelines [45], depending on the
individual, a multimodal treatment, often including a
combination of drug treatment and non-pharmacological
treatment, should be offered. If left untreated, adult
ADHD can be accompanied by severe functional impair-
ments and limitations in multiple areas of life and is fur-
ther associated with an increased risk of multiple mental
health and social difficulties as well as premature mortality
[46–50]. Some adults with ADHD succeed in developing
coping strategies to mitigate the impact of their symptoms
on their work and social life [51]. However, these strat-
egies may no longer be sufficient in situations of excep-
tional stress, such as the COVID-19 pandemic, which
severely disrupted people’s everyday routine (e.g. introduc-
tion of home office or home schooling). It is therefore es-
sential to ensure continuous availability of therapeutic
support for patients with clinically relevant ADHD not
only beyond childhood and adolescence, but also during
such exceptional situations.
Telepsychiatry for adults with ADHD
In their recent review of the literature, Spencer and col-
leagues [52] identified 11 relevant primary studies with
sample sizes of at least 20 participants investigating the
use of telepsychiatry in patients with ADHD. Overall,
the results were promising; telepsychiatry was both well
accepted and valued by patients and also associated with
improved outcomes. However, only one of the studies
also included an adult sample. Moreover, telepsychiatry
was used either to augment standard care (additional
telepsychiatric sessions on evidence-based pharmaco-
logical care for ADHD and psychoeducation on the
neurobiology of ADHD) or for consultation (virtual
visits with psychiatrist or psychologist, who then con-
sulted with the patient’s primary care provider) or
evaluation purposes, not as a (temporary) substitute
for face-to-face treatment.
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The question of the suitability of telepsychiatric treat-
ment for (adult) patients with ADHD seems particularly
pertinent because of typical impairments associated with
this disorder. On the one hand, patients might find it
more difficult to stay focused during an off-site session
due to the abundance of potential distractors in their en-
vironment. They may also find it difficult to cope with
the demands of a telepsychiatric session in terms of time
management and self-organisation, as these skills usually
tend to be impaired in ADHD. Moreover, the setting in
itself, using a media device like a smart phone or com-
puter, might lead to patients carrying out activities sim-
ultaneously to the psychotherapeutic session. Thus, we
see tangible risks for increased distractibility with this
form of psychotherapy in this specific group of patients.
On the other hand, however, in addition to the advan-
tages of telepsychiatry already discussed above, telepsy-
chiatric interventions could also counteract the negative
effects of patients’ disorganisation, e.g. by saving travel
time and thus alleviating experiences of stress due to dif-
ficulties in time management [53]. Furthermore, adults
with ADHD may experience a range of financial prob-
lems [54], and telepsychiatry would allow those affected
to save on costs associated with traveling to the therapy
sessions. Hence, further research on how this specific
group of patients experience telepsychiatric care is
necessary.
The present study
The aim of the present study was to explore how outpa-
tients with ADHD and their therapists experienced ther-
apy sessions under the adjustments necessary due to the
COVID-19 pandemic. Each session took place either
face-to-face with the therapist wearing a face mask, via
videoconferencing, or via telephone; we subsume the lat-
ter two modalities under telepsychiatry. We intended to
address two questions in particular. First, does telepsy-
chiatric treatment offer a viable (temporary) alternative
to face-to-face treatment in adult ADHD? As discussed,
this question is important as several symptoms often as-
sociated with ADHD might result in telepsychiatry being
particularly challenging for these patients. Second, how
does on-site treatment with the therapist wearing a face
mask compare to telepsychiatric treatment options? We
are not aware of a comparative study investigating this
question. Although explored in a specific group of pa-
tients, this examination of the impact of the therapist
wearing a face mask will be of general interest.
Patients’ and therapists’ experience with the sessions
were explored both quantitatively and qualitatively; each
patient and therapist completed the questionnaire once
during the assessment period with both questionnaires
being completed for the same session. We assessed
patients’ experience and evaluation of the session,
including their satisfaction with the therapy, and were
also interested in patients’ and therapists’ ratings of TA.
We further assessed whether patients felt the current
sessions were comparable or inferior to the pre-COVID-
19 sessions and what setting they would prefer out of a
number of different options. Finally, we asked patients




This exploratory, quantitatively driven mixed-method
study (combining quantitative questionnaire data and
qualitative data from responses to open-ended questions
[55–57];) with an independent measures design aimed to
explore ADHD patients’ and therapists’ experience of a
specific therapy session during the COVID-19 pandemic
in one of the following three treatment modalities: face
to face, videoconferencing, and telephone.
Sample and recruitment
Participants in this study were adults with a diagnosis of
ADHD according to the 10th revision of the Inter-
national Classification of Diseases [58], who were receiv-
ing treatment at a specialised outpatient clinic (multi-
modal therapy combining pharmacological therapy and
psychotherapy, primarily for ADHD but – as per NICE
guidelines [45] and the practice recommendations of the
German Association for Psychiatry, Psychotherapy and
Psychosomatics [59] – also for other neurodevelopmen-
tal or mental health conditions where appropriate). Data
were collected between the end of April and the end of
June 2020.2 The type of treatment modality during the
pandemic was determined based on each patient’s needs
and preferences. Patients were seen by the same therap-
ist throughout the study. All patients with sufficient
command of the German language and who attended a
treatment session during the study period with one of
the two participating therapists were offered the oppor-
tunity to participate in the research.
Overall, therapists completed 97 questionnaires. For
66 of these questionnaires a patient questionnaire was
returned (response rate of 68%). Data from six patients
had to be excluded, either because essential information
was missing (n = 3), their data were collected at a point
at which the wearing of a face mask was not mandatory
for therapists (n = 2), or because they did not have a
diagnosis of ADHD (n = 1), yielding a final sample size
of N = 60 (face to face: n = 29; videoconferencing: n =
11; telephone: n = 20). The two therapists involved in
2This means that most of the data collection took place during the
extraordinary situation in Switzerland, which lasted from the 16th of
March until the 19th of June.
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the study recruited similar numbers of patients (50 and
47) and had a similar response rate (66 and 70%).
Thirty-one patients from Therapist A and 29 patients
from Therapist B were included in the final sample. The
two therapists conducted similar numbers of face-to-
face and telepsychiatric sessions (p = .993), although, at a
descriptive level, Therapist A conducted more sessions
over the phone (12 vs. 8) whereas Therapist B ran more
videoconferencing sessions (7 vs. 4).
Measures
Session evaluation questionnaire
The Session Evaluation Questionnaire (SEQ [60]) is used
to assess patients’ self-reported immediate session ex-
perience. It consists of 21 items scaled according to a se-
mantic differential (e.g. from 1 shallow to 7 deep). The
factor structure of the English original was replicated in
the German version for the factors session depth and ses-
sion smoothness (both in-session processes) and post-ses-
sion positivity (post-session impact), but not for arousal
[61]. Therefore, arousal was not included in the present
study. Studies that investigated construct validity re-
ported statistically significant positive correlations with
therapeutic alliance [61]. Higher scores indicate more
depth, higher smoothness, and higher post-session posi-
tivity. Cronbach’s alpha values in the current study were
satisfactory to good with .70 (depth), .77 (smoothness),3
and .87 (post-session positivity).
Client satisfaction questionnaire
The Client Satisfaction Questionnaire (CSQ [62]) is an
eight-item self-report scale that assesses patient satisfac-
tion with the mental health services indicated by means
of 4-point Likert-type responses. The German version of
the CSQ [63] has been reported to be reliable (Cron-
bach’s alpha = .90) and to possess good psychometric
properties overall [64]. The instructions were slightly
adapted for the current study, stating “when answering
the following questions, please consider the therapy ses-
sions as they took place today”. The mean score is re-
ported with higher scores indicating higher satisfaction.
Cronbach’s alpha was good (.84).
Working Alliance inventory
The Working Alliance Inventory (WAI) is a common
measure used to assess therapeutic alliance [33]. We ap-
plied the short revised version of the WAI for patients
(WAI-SR-P) and therapists (WAI-SR-T) [65]. Both ver-
sions consist of 12 items; answers are provided on a 5-
point Likert scale ranging from seldom (1) to always (5).
The German version of the WAI-SR-P has good internal
consistency, with Cronbach’s alpha ranging between .81
and .91 for the subscales [66, 67]. For the German ver-
sion of the WAI-SR-T, only limited data are available;
for this study, the 12-item version recommended by
Munder [68] was used. The items of both WAI-SR ques-
tionnaires assess three subscales (bond, tasks, and goals).
Mean scores are reported for each scale, with higher
scores indicating a stronger working alliance. Cronbach’s
alpha values for the WAI-SR-P were acceptable to good
for bond (.76) and tasks (.80), but questionable for goals
(.66). As deleting an item on the scale did not improve
Cronbach’s Alpha, the scale was left unchanged. The
corresponding values for the WAI-SR-T were acceptable
at .72, .72, and .75, respectively.
Global assessment of functioning score
The Global Assessment of Functioning (GAF) scale [69]
was used to assess overall patient functioning from the
therapist’s perspective. The GAF score ranges from 1 to
100, with 100 representing a high functioning individual
that is not experiencing any symptoms.
Questions regarding the patient’s experience with the
COVID-19 pandemic
A self-developed four-item questionnaire was used to as-
sess patient experience with the COVID-19 pandemic.
Patients were asked (1) whether they belonged to the
high-risk group (yes/no) and to indicate the extent to
which (2) their everyday life was affected by the COVID-
19 pandemic, (3) they felt distressed because of the pan-
demic, and (4) they experienced fear because of the pan-
demic (all 5-point Likert-scales ranging from 1 not at all
to 5 very much). The German questions and English
translations can be seen from the Supplementary File 1
(Table A, questions C1-C4).
Specific closed and open-ended questions regarding the
session (patient questionnaire)
Patients were asked whether they felt the current treat-
ment modality was better, worse or comparable to the
pre-COVID-19 therapy sessions, and how they would
rank five treatment modality options (telephone; video-
conferencing; face-to-face, in compliance with hygiene
and distance rules; face-to-face with the therapist wear-
ing a face mask; face-to-face with a plastic divider separ-
ating therapist and patient) in terms of preference if they
had a free choice (see Supplementary File 1, Table A,
questions F1 and F2). Moreover, patients were asked
two open-ended questions: (1) “Was there anything you
particularly liked about the way today’s session took
place?”, and (2) “Was there anything you felt uncomfort-
able with or disliked about the way today’s session took
3Due to a technical error, item 6 was missing from the questionnaire,
which means that the subscale smoothness consisted of 4 instead of 5
items.
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place?” (see Supplementary File 1, Table A, questions
OP1 and OP2, for the original German wording).
Specific closed and open-ended questions regarding the
session (therapist questionnaire)
Therapists were asked how many sessions patients had
already had in the current modality and why that modal-
ity had been chosen (severity of the present condition,
patient belonging to a risk group, patient request, other).
Whether a specific treatment modality was requested by
a patient may influence their acceptance of and experi-
ence with that modality. Therefore, we created a dichot-
omous variable patient request (yes/no). For some
patients, more than one rationale for the allocation to a
specific modality was reported. All patients for whom
the therapist ticked the box patient request were allo-
cated to the patient request group.
Therapists were also asked how they evaluated the
current session modality compared to the normal mo-
dality for this specific patient (open-ended question):
“For this patient, how do you evaluate the way the ther-
apy sessions are currently conducted compared to the
way they normally take place?” (see Supplementary File 1,
Table A, question OT1, for the original German
wording).
Procedure
Therapists informed eligible patients about the study at
the end of a therapy session and provided them with the
information sheet and their personal code. Patients were
asked to complete the survey shortly after the session as
the questions related to their experience of the therapy
session; 70 % of participants completed the survey on
the same day. Data were collected through the online
platform Qualtrics (Qualtrics, Provo, UT). Participants
provided informed consent by ticking boxes to indicate
that they had understood the aims of the study and their
rights. The survey consisted of three questionnaires
(SEQ, CSQ, and WAI-SR-P) and a number of questions
on the patients’ experience with the session and the
treatment modality, how the pandemic affected them in
general, and demographics.
The therapists also received an information sheet and
were asked to provide informed consent, as the comple-
tion of the WAI meant that they, too, were participants
in this study. The therapists’ Qualtrics survey consisted
of the WAI-SR-T, questions on their perception of the
specific session, general questions regarding the session
(reasons for modality chosen, number of sessions in the
current modality) and questions regarding the patient
(GAF score, psychiatric diagnoses). Therapists used the
same code as the patient, which allowed matching the
data. The code was encrypted before being saved to the
data file.
Neither patients nor therapists received payment in re-
turn for their participation. The Cantonal Ethics Com-
mittee of Bern filed a letter of non-competence and
stated no objection to the study (Req-2020-00421).
Data analysis
Quantitative analyses
Data were screened for outliers, and three scores that
were more than 3 standard deviations from the mean
(one each on the following scales: CSQ, SEQ depth, and
WAI-SR-T bond) were winsorized and replaced with the
next lowest or highest value. All statistical analyses were
conducted with IBM SPSS 26 (IBM® SPSS® Statistics
Version 26). A significance level of .05 was set, and all p
values are reported two-tailed. Because of the small sam-
ple size for the videoconferencing group, the results for
this group are reported at a descriptive level only; for
statistical analyses, the data from the videoconferencing
group and the telephone group were collapsed into a tel-
epsychiatry group. The main outcome variables were the
SEQ, CSQ, WAI-SR-P, and WAI-SR-T. The sequential
multiple regressions with modality as the predictor (di-
chotomized as face-to-face vs telepsychiatry) were ad-
justed for the variable therapist and the number of
sessions the patient had already had in the current mo-
dality. A sequential multiple regression model was
chosen to control for potential differences between the
two therapists involved in the study and for the fact that
the number of sessions that had already been attended
in the relevant modality was higher for the telepsychia-
tric group than for the face-to-face group (see Table 1).
According to post-hoc calculations with G*Power 3.1,
achieved power to detect a medium effect with the
current sample was good (.84). As all patients who were
eligible and attended a treatment session during the rele-
vant time period were approached, a priori power calcu-
lations would not have been meaningful for this study.
For the analyses of patients’ preferences, chi square sta-
tistics and frequencies were calculated.
Qualitative analyses
Patients’ and therapists’ responses to the open-ended
questions were analysed for (1) factors that were per-
ceived as positive (patient) or facilitated the session
(therapist), and (2) factors that were perceived as nega-
tive (patient) or complicated the session (therapist). An
inductive content analysis following the stages described
by Elo and Kyngas [70] was conducted for each treat-
ment modality group for responses from the patients
and the therapists by one of the first authors. Content
analysis allows large amounts of text to be organised
into a smaller number of meaningful categories [71].
Topics referred to in several of the responses are re-
ported in the result section. Quotes were translated from
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German to English by one of the first authors and the
other first author independently verified the translations
of the quotes. The German original wording of the
quotes included in the present paper can be seen from
Table B in the Supplementary File 1.
Results
Sample characteristics
Mean age of the overall sample was 39.10 (SD = 11.19)
years, 55% were male, and they had attended an average
of 2.42 (SD = 1.49) sessions in the relevant modality, i.e.
the modality in which their sessions took place at the
time of data collection. In 75.9% of cases (n = 58 as data
for two cases were missing), the therapist reported that
the modality had (also) been requested by the patient.
The patients had 1.68 (SD = 0.65, range 1 to 3) psychi-
atric diagnoses on average (including the diagnosis of
ADHD). The most common comorbidity was a F30–39
diagnosis (mood disorders; 27%), followed by F40–49
(neurotic, stress-related and somatoform disorders;
22%), F10–19 (substance use disorders; 7%), and F60–69
(personality disorders, impulse-control and “habit” disor-
ders; 7%). Patients’ average GAF score was 68.62 (SD =
11.84). In terms of highest education, 5% had completed
compulsory school, 27% had completed an apprentice-
ship, 25% had their school-leaving examination (a quali-
fication to enter university), and 43% had a university
degree. Details on sample characteristics by group can
be seen from Table 1.
In terms of a priori differences between the groups,
patients in the telepsychiatric group had attended statis-
tically significantly more sessions in the present modality
than patients in the face-to-face group, t (47.94) = − 5.03,
p < .001, d = 1.30. All other group differences, including
those on three potential confounding variables consid-
ered (age, questions regarding patients’ experience with







p (Cohen’s d) a
Number of sessions 1.59 (0.87) 2.91 (1.81) 3.35 (1.39) .000 (1.30)b
Gender (% male) 48.3% 63.6% 60.0% .311 (0.26)c
Age 39.62 (11.22) 38.00 (9.89) 38.95 (12.26) .730 (0.09)b
Highest education .067 (−)d
Compulsory school 3.4% 9.1% 5.0%
Apprenticeship 27.6% 27.3% 25.0%
School-leaving examination 24.1% 18.2% 30.0%
University degree 44.8% 45.5% 40.0%
No of psychiatric diagnoses (incl. ADHD) 1.66 (0.61) 1.55 (0.52) 1.80 (0.77) .749 (0.08)b
Comorbidities
F10–19 6.9% 0.0% 10.0% 1.000 (−)d
F30–39 34.5% 18.2% 20.0% .185 (0.35)c
F40–49 20.7% 36.4% 15.0% .859 (0.05)c
F60–69 0.0% 0.0% 20.0% .113 (−)d
GAF-scoree 67.59 (11.92) 72.55 (5.85) 67.95 (14.02) .519 (0.17)b
COVID-19 high risk group 10.3% 0.0% 15.0% 1.000 (−)d
Impact of COVID-19
change to everyday life 3.62 (1.05) 4.00 (1.33) 4.10 (1.25) .145 (0.38)b
distress 2.83 (1.10) 2.80 (1.32) 3.25 (1.33) .395 (0.22)b
fear 2.38 (1.18) 2.60 (0.84) 2.70 (1.17) .329 (0.25)b
Allocation to treatment modality based on patient request 1.000 (0.00)c
yes 75.9% 63.6% (77.8%)* 75.0%
no 24.1% 18.2% (22.2%)* 25.0%
Note: The values represent either the mean, with the standard deviation reported in brackets, or the percentage of cases within the relevant group. School leaving
examinations are similar to A levels in the UK and qualify the individual to study at a university. *Information for 2 patients was missing in this group, which is
why two percentages are reported. The first refers to N = 11 (total cases), the second to N = 9 (cases for which the information was available). aTo check for
statistically significant a priori differences between groups, the face-to-face group was compared to the collapsed telepsychiatry groups (telephone and
videoconferencing) because of the small sample size in the videoconferencing group. bTwo-samples t-test. cχ2 test. dFisher’s exact test. eAs data was provided by
two therapists, a second t-test with Z standardized GAF scores (standardization within therapist) was conducted, which yielded similar results, t(58) = − 0.62,
p = .541, d = 0.16
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the COVID-19 pandemic, and GAF) did not reach statis-
tical significance (see Table 1).
Quantitative analyses
SEQ, CSQ, WAI-SR-P, and WAI-SR-T
Table 2 presents an overview of the mean scores for
each of the three modalities and the standardized regres-
sion coefficients of the treatment modality variable
(face-to-face vs. telepsychiatric session [telephone and
videoconferencing combined]) adjusted for therapist and
number of sessions for each of the sequential multiple re-
gressions (see Supplementary File 1, Tables C-L, for the
full regression tables).4 The telepsychiatric sessions were
rated as significantly less deep than the face-to-face ses-
sions (B = − 0.89, p = .001). While not statistically signifi-
cant in step 1 (B = 0.01, p = .995), the predictor number
of sessions approached significance after the predictor
modality was introduced (B = 0.17, p = .062). We ex-
plored the association between number of sessions and
SEQ depth in more detail. Individual scatterplots per
group revealed small, non-significant associations be-
tween number of sessions and depth for the face-to-face
group (r = .26, p = .168) and the telephone group (r =
.10, p = .672). By contrast, patients in the videoconfer-
encing group tended to experience more depth to their
session the more sessions they had already had in that
modality (r = .39, p = .243), an association that increased
considerably after excluding an extreme value (r = .68,
p = .030).
None of the other models reached statistical signifi-
cance, i.e. treatment modality was not a statistically sig-
nificant predictor for session smoothness, post-session
positivity, satisfaction with the treatment received, or
TA as rated by both patients and therapists.
Patients’ self-reported preferences
Patients were asked whether they preferred the therapy
sessions as they were before the COVID-19 pandemic,
whether it made no difference to them, or whether they
preferred the current sessions. Overall, 56.7% reported
that they felt it made no difference, followed by 38.3%
who preferred the sessions as they were before the pan-
demic. A chi-square analysis comparing the face-to-face
group and the telepsychiatry group revealed no statisti-
cally significant differences in responses (see Table 3).
An interesting observation was that the proportion of
patients in the face-to-face group who felt that the
current session was either no different or even better
than the pre-COVID-19 sessions outweighed those who
felt it was worse independently of whether they had been
allocated on request or not, whereas in the telepsychia-
tric group this observation only applied to those who
had requested the modality. Patients in the telepsychia-
tric group who had not requested the format were some-
what more likely to indicate the current sessions were
worse than the pre-COVID-19 sessions. Note, however,
that these descriptive observations are based on very
small numbers per subgroup.
Participants were also asked about their treatment mo-
dality preferences (from most preferred to least pre-
ferred) if they were to have a choice among five
options.5 The three groups differed in terms of their
preferences, as can be seen from Fig. 1. The face-to-face
group had a strong preference for on-site treatment, al-
though a majority would prefer sessions in compliance
with hygiene and distance rules. In the videoconferenc-
ing and telephone groups, for about half of the patients
their current modality was their most preferred one,
whereas the other half would prefer on-site sessions,
mostly in compliance with hygiene and distance rules.
Descriptive analyses of the preferences within the face-
to-face options revealed an overall preference for ses-
sions following hygiene and distance rules only across
the three groups, whereas no clear preference could be
identified in terms of videoconferencing vs telephone
sessions. In the face-to-face group, 58.6% preferred vid-
eoconferencing, whereas a much clearer picture emerged
in both the videoconferencing group, in which 90.9%
ranked videoconferencing higher than telephone, and
the telephone group, where 80.0% ranked telephone
higher than videoconferencing.
Qualitative analyses
What did patients like and dislike about the specific
session?
Although patients were asked what they liked and dis-
liked about the specific session modality, the vast major-
ity of responses were more general and seemed to refer
to the session as a whole.
In the face-to-face group, most of the positive aspects
mentioned concerned either the therapist’s behaviour
(e.g. empathic, makes me feel taken seriously, friendly,
4Sensitivity analyses comparing the face-to-face and telephone group
were conducted to explore whether the results were affected by col-
lapsing the two telepsychiatric modalities. Results were fairly similar to
the main analyses, although two trends (p < .10) emerged, one for
WAI-SR-P bond and WAI-SR-T tasks, indicating lower ratings in the
telephone condition than in the face-to-face condition for both in-
stances. Telephone sessions were still rated as significantly less deep
than face-to-face sessions (B = − 0.60, p = .049). The regression coeffi-
cients from the sensitivity analyses can be seen from Table M in the
Supplementary File 1.
5Although therapists indicated for the majority of patients that the
modality choice was based on or in line with the patients’ request (see
Table 1), a patient’s request may not necessarily be identical with their
preferred choice out of the five options (e.g. a patient may have
experienced light symptoms but still wanted to attend the therapy
session and therefore requested changing the format to a
telepsychiatric session).
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understanding) or the therapy session itself (e.g. an indi-
vidual aspect that patients found particularly useful
about the session or being able to talk to the therapist in
general; e.g. Patient 30: “the time and therapeutic discus-
sion we had”). The most common issue identified with
the specific session was that the mask hampered com-
munication (e.g. no feedback from facial expressions,
therapist harder to understand acoustically), which was
mentioned by about 17% of patients. For example, Pa-
tient 32 wrote, “As for my therapist per se, ( …), I am
very satisfied. However, wearing a mask was a bit annoy-
ing because you can no longer see the facial expressions
properly. But of course I understand the necessity of this
measure.” The remaining points raised concerned ad-
ministrative issues (e.g. having to wait, temporary reloca-
tion of therapy sessions to a different building).
Positive aspects identified by the videoconferencing
group were related either to the therapist/therapy ses-
sion itself or to organisational advantages of the
modality (e.g. Patient 25 wrote, “It is straightforward. If
the doctor is running late, no time is lost because I can
do something useful in the meantime rather than doing
nothing in the waiting room.”). Some patients also men-
tioned that they appreciated having the opportunity to
conduct a videoconferencing session, felt it was uncom-
plicated or rated it even on a par with face-to-face ses-
sions. The following negative aspects were mentioned by
two patients (18%) each: Technical problems (e.g. poor
connection), lack of distance from everyday life (e.g. Pa-
tient 24 wrote, “( …) Mutual presence was deeper at
physical meetings. On my part, this may be due to the
fact that, because there was no travelling to the therapy
session, the change from home office to therapy session
was too abrupt.”), and specific issues with the modality
(e.g. more difficult to concentrate or feeling less
present).
The majority of the telephone group’s positive com-
ments again referred to the therapist or the therapy









Pre-COVID-19 sessions vs current session .917 (0.14)
pre-COVID-19 better 37.9% 27.3% 45.0%
no difference 55.2% 72.7% 50.0%
current better 6.9% 0.0% 5.0%
Note: For the Fisher’s exact test, the face-to-face was compared to the collapsed telepsychiatry groups (telephone and videoconferencing) because of the small
sample size of the videoconferencing group
Table 2 Questionnaire Means and Standard Deviations per Treatment Modality Group and Adjusted Standardised Regression









depth 5.50 (0.73) 4.47 (1.07) 5.12 (0.89) −0.49 .001
smoothness 5.68 (1.02) 5.14 (1.40) 5.49 (1.05) −0.10 .508
post-session positivity 5.36 (1.12) 5.35 (1.14) 5.44 (0.98) 0.06 .731
CSQ
total score 3.75 (0.30) 3.63 (0.38) 3.71 (0.30) −0.23 .143
WAI-SR-P
bond 4.41 (0.51) 4.39 (0.60) 4.21 (0.72) −0.16 .322
tasks 3.99 (0.52) 3.75 (0.68) 3.78 (0.68) −0.27 .084
goals 3.95 (0.58) 4.14 (0.49) 3.93 (0.77) 0.08 .612
WAI-SR-T
bond 4.16 (0.50) 4.30 (0.33) 4.04 (0.53) −0.19 .207
tasks 3.75 (0.45) 3.93 (0.37) 3.61 (0.50) −0.19 .221
goals 3.62 (0.47) 3.91 (0.44) 3.53 (0.39) −0.03 .844
Note: The values represent the mean; the standard deviation is reported in brackets. The maximum scores for the SEQ subscales, the WAI-SR subscales, and the
CSQ scale are 7, 5, and 4, respectively. The standardized beta coefficient for the predictor treatment modality (face-to-face or telepsychiatry [telephone and
videoconferencing combined]; reference group: face-to-face), which is adjusted for therapist and number of sessions, is reported for each outcome variable
together with the p value of the regression coefficient
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session. Some patients explicitly mentioned organizational
advantages (e.g. saving time, no need to use public trans-
port) or advantages that related to their symptoms (e.g.
Patient 21 wrote, “The fact that the session is a conversa-
tion only without look and facial expressions also has ad-
vantages, because this way I am more focused on the
content and not distracted or influenced by visual stimuli
or by my therapist’s behaviour.”)”. About 15% of patients
voiced concerns regarding the absence of visual input (e.g.
Patient 28 wrote, “( …) A lot of things that I can normally
assess visually were missing. E.g., I couldn’t tell from the fa-
cial expressions whether my question had been understood.
This only became clear with the [therapist’s] response. (
…)”), felt that speaking over the phone was impersonal, or
reported encountering administrative problems (e.g. poor
sound quality). Circumstances identified as having the po-
tential to make a telephone session more difficult were
not being sufficiently familiar with the therapist and the
absence of mimic feedback when discussing specific (per-
sonal) topics. Conversely, patients felt that a telephone
session worked well to discuss medication or when there
was already an established bond of trust with their
therapist.
Complicating and facilitating factors identified by the
therapists
Regarding face-to-face sessions, most of the complicat-
ing factors, which were mentioned for a little more than
half of the patients, were related to communication diffi-
culties caused by the face mask (e.g. reduced access to
facial expression cues, acoustic communication prob-
lems, some patients feeling insecure or uncomfortable).
For instance, Therapist B wrote for Patient 39, “Has
initial difficulties coming to terms with the face mask, (
…) keeps asking questions and thinks s(he) has not under-
stood me acoustically. This interrupts the flow of conver-
sation.”. For about 40% of the patients, therapists felt
that the sessions were fairly or fully comparable to the
pre-COVID-19 sessions. A pre-existing bond of trust
was reported to mitigate negative effects of wearing a
mask, and therapists perceived the mask to be less of a
problem for some patients than for others (e.g. Therapist
A wrote for Patient 10, “Barrier due to mask because of
significant reduction of mimic response and slight prob-
lems with comprehensibility – however, with a young, (
…) reflective patient the session was sufficiently feasible.”,
although it was not possible to identify specific factors
from the responses provided. Finally, in a small number
of cases therapists reported positive effects of wearing a
face mask as some patients seemed more attentive dur-
ing the session as a result. Therapist B wrote for Patient
35, “Usually, this patient avoids eye contact. Under these
circumstances, however, s (he) maintained eye contact re-
markably well ( …)” , and for Patient 40, “The impression
is given that the covering of the region of the mouth made
the patient pay more attention and not drifting off as
[much as] usual.”.
The issues most commonly identified with videocon-
ferencing sessions were: not being able to get a full pic-
ture of the patient (both figuratively and literally
speaking; e.g. limited access to body language cues;
slightly more than half of the cases) and limitations in
terms of therapeutic measures that could be employed
(e.g. using whiteboards; raised for nearly half of the
cases). Illustrating both points, Therapist A wrote for
Patient 24, “limited due to the physical response not
Fig. 1 Preferred Modality If Patients Had Free Choice Among Five Options. Note. This figure shows the percentage of patients in each group that
indicated a specific option as their first choice
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being completely visible and the considerable difficulties
in completing specific tasks with the patient, ( …) e.g. gen-
erating a to-do list ( …)” . Only few technical issues were
reported. A mitigating factor mentioned by the thera-
pists was the main goal of the session; for instance, the
limitations of a videoconferencing session were less im-
portant for sessions that focused on medication rather
than psychotherapeutic work.
In terms of telephone sessions, the issues raised most
frequently were the lack of access to body language and
facial expression cues and the associated limited insight
into patients’ affective or emotional reactions (about one
third of the cases). For example, Therapist A wrote on
the session with Patient 28, “Absence of emotional re-
sponse or its equivalents in facial expressions and ges-
tures. Patient is well known, but limitations were still
significant because of it [the lack of visual information]”.
In some cases, therapeutic measures were limited, or the
therapist felt that patients seemed more distracted than
in regular face-to-face sessions. In addition, telephone
sessions were perceived as less suitable for patients who
were very unwell and/or needed to discuss difficult
topics (e.g. Therapist B wrote for Patient 51, “As one
parent recently passed away, it is difficult to discuss
everything only over the phone. It would be better for the
patient to leave his/her home to ease the burden [of the
loss] as well”). Conversely, speaking over the phone
worked well for sessions that focused on medication. For
about one in three cases, therapists reported that they
felt the sessions were at least fairly comparable to pre-
COVID-19 sessions and/or that the restrictions were not
particularly problematic.
Discussion
This study sought to explore adult ADHD patients’ and
their therapists’ experience of a therapy session during
the COVID-19 pandemic. Our results indicate that pa-
tients who attended a face-to-face session with the ther-
apist wearing a face mask experienced significantly more
depth to their session than patients who received tele-
psychiatric care. Descriptively, depth was lowest in the
video-conferencing group, but further exploratory ana-
lyses suggested that depth in that group increased with
the number of sessions. Thus, over time the difference
in session depth between modalities might decline,
which would be in line with the findings reported by
Morgan and colleagues [72], who did not observe statis-
tically significant differences in session depth for tele-
mental health vs face-to-face psychological or psychiatric
services. We can only speculate about possible explana-
tions for an (initially) lower session depth rating in the
telepsychiatry group. Patients might experience initial
technical difficulties, need time to adapt to the new for-
mat, or need time to become accustomed to discussing
personal or intimate topics during a telepsychiatric ther-
apy session.
No statistically significant effects of treatment modality
were observed for any of the other outcome variables.
Post-session positivity did not differ between modalities,
which suggests that there were no major differences in
the effects of face-to-face and telepsychiatric sessions on
patients’ post-session well-being. Also, patients’ satisfac-
tion with the services received did not differ depending
on modality, and no statistically significant differences in
patients’ ratings of TA across the three conditions were
observed. Although no direct comparison to pre-
COVID-19 TA is possible, the results do not suggest
that one type of adjustment made because of the pan-
demic might be particularly detrimental to TA as per-
ceived by patients. Contrary to some previous studies
(see e.g. [33]), no statistically significant difference in
therapist TA rating depending on treatment modality
was observed either. This difference to previous findings
might be due to the fact that the therapists in the
present study already knew their patients. According to
Simpson and Reid [33], lower TA ratings for telepsychia-
try were observed mainly in the early stages of an inter-
vention. The findings from our study indicate that the
modality chosen may have little bearing on TA for both
patients and therapists. In sum, we observed few differ-
ences between face-to-face sessions (with the therapist
wearing a face mask) and telepsychiatric sessions for
adult patients with ADHD, and it seems possible that
the difference that was observed would decrease as the
number of sessions in the new modality increases.
In line with other findings reported thus far, two-
thirds of all patients felt their sessions in the current
treatment modality were not inferior to the pre-COVID-
19 modality, and there was no statistically significant dif-
ference in that respect between patients in the face-to-
face group and in the telepsychiatry group. If patients
could choose freely from a number of options, however,
over 60% of all patients ranked on-site treatment with
adherence to hygiene rules rather than on-site treatment
with the therapist wearing a face mask or using a plastic
divider as their first choice for on-site treatment. Only a
few of the patients in the face-to-face group opted for a
telepsychiatric treatment modality as their first choice,
whereas about half of the patients in the telepsychiatry
group selected their current telepsychiatric treatment
modality as their first choice. In terms of preferences for
telephone vs videoconferencing, the majority of the pa-
tients in the telepsychiatric group clearly favoured their
current modality, whereas no strong preference for one
over the other was observed in the face-to-face group.
Despite the fact that the majority of patients reported
preferring a face-to-face modality that did not involve
the therapist wearing a face mask, only five (i.e. 17%) of
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the patients in the face-to-face group actively mentioned
issues related to the therapist wearing a mask, such as
lack of facial expression cues or issues with acoustic
comprehension, as something they disliked about their
session. Rather, the results of the content analysis sug-
gest that – across all conditions – patients’ experience of
the session was mainly shaped by positive aspects related
to the therapist or the specific session. The therapists, by
contrast, mentioned issues relating to their wearing a
mask in about half of the cases. However, in a few cases
they also reported that the absence of visual distractors
(facial cues) seemed to have resulted in patients focusing
more on the content of the session. Similar results were
reported by Webb [73], who identified an increased
treatment focus as a main theme in her qualitative study
on clinicians’ experiences with cognitive-behavioural
therapy based telephone interventions. It is possible that
therapists generally attach more importance to the ques-
tion of the effects of the face mask than their patients.
At least in the adoption of telephone interventions, the
lack of non-verbal cues seems to be a key concern for
therapists [34, 74]. Additionally, the open-ended ques-
tions for patients and therapists were formulated some-
what differently, which may have contributed to the
therapists discussing the effects of wearing a mask more
frequently. Either way, the fact remains that the vast ma-
jority of the patients in the face-to-face group did not
feel the need to raise issues with the face mask.
In the telepsychiatric groups, in addition to the posi-
tive comments on the therapy session in general, pa-
tients additionally highlighted organisational advantages
such as saving time. In the telephone condition, another
advantage mentioned was the reduced distraction by vis-
ual information, which corresponds to findings from
other research [75]. In the videoconferencing group,
some emphasised a lack of distance from everyday life or
raised specific issues with the modality, such as feeling
less present. In the telephone group, three (15%) patients
raised issues related to the lack of visual cues and a simi-
lar number felt the telephone session was somewhat im-
personal. Similar to the face-to-face group, the therapists
were again much more concerned with the limitations of
the telepsychiatric modalities, particularly the full or par-
tial lack of visual cues, than were their patients. A key
aspect was the therapists’ perception that the lack of vis-
ual cues limited their ability to interpret the patient’s ex-
perience. This seems to be a common concern among
therapists. In a study by Olwill and colleagues [74],
which surveyed Irish psychiatrist’ experience of tele-
phone consultations during the COVID-19 pandemic,
this point was endorsed by 25 of the 26 respondents.
The responses to the open-ended questions on how
the session was experienced also provided some insight
into the circumstances under which a telepsychiatric
session was considered more or less suitable. One aspect
mentioned by both patients and therapists was session
content. Telepsychiatric treatment was perceived to be
more suitable if the session focused on discussing medi-
cation or other issues that were not too personal in na-
ture. If more sensitive/intimate topics needed to be
discussed, a face-to-face session was considered prefera-
ble. Therapists felt that telephone consultations were
less appropriate for patients who were particularly un-
well. Both patients and therapists also mentioned that,
because of the limitations of telepsychiatry, some thera-
peutic methods could not be implemented (e.g. using
white boards for to-do lists or plans), thereby highlight-
ing another factor that may need to be considered when
deciding on the modality of a session.
Strengths, limitations, and future research
One of the strengths of this study is that it sheds light
on both patients’ and therapists’ experiences with differ-
ent treatment settings and also provides us with qualita-
tive information about these experiences. Moreover, to
our knowledge it is the first study to investigate how an
on-site session with the therapist wearing a face mask
compares to telepsychiatric provision, both of which are
potential adjustments that allow for continued treatment
during a situation such as the COVID-19 pandemic. Yet,
the generalisability of our results to other psychiatric
disorders will need to be examined in future studies; de-
pending on the predominant symptoms, patients may
react differently to a scenario in which the therapist is
wearing a face mask (see e.g. [9]). Moreover, recommen-
dations regarding face masks have changed and future
studies should examine whether the present results can
be replicated if both therapist and patient wear a face
mask during on-site sessions.
The focus on adult patients with ADHD is another
strength of the study, as research on the suitability of
telepsychiatric treatment for adult patients with ADHD
is particularly scarce [52] and the various symptoms of
ADHD, such as inattentiveness and organisational defi-
cits, have distinct potential to interfere with this type of
treatment modality. Due to ADHD’s high prevalence in
adults, often demanding continuous treatment, and its
frequent presentation with severe psychiatric co-
morbidities, patients with ADHD are a particularly im-
portant group to study. This research offers a valuable
contribution to the still understudied topic of adult
ADHD. While our ADHD sample was comparable in
terms of certain aspects such as comorbidity of major
mood disorders (e.g. [76]), the comorbidity of substance
abuse was lower than what has been reported in other
studies [77, 78]. Moreover, the number of patients with
high educational achievements was above average. These
aspects should be taken into account in terms of the
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generalisability of the findings to other patients with
ADHD. Also, future research should investigate whether
our results can be replicated under non-pandemic con-
ditions. Fear of contracting the virus may have resulted
in on-site sessions being perceived as less desirable than
under normal circumstances, which may have inflated
patients’ ratings of the telepsychiatric sessions.
Randomized allocation to treatment modality was not
possible in this study. We identified a number of potential
confounding variables and examined whether there were
any group differences for these variables. Patient age was
included because younger patients may be more familiar
and confident with the use of telecommunication, which
could have distorted the results in case of systematic dif-
ferences between the three groups. The self-reported ex-
tent to which the patient was affected by the COVID-19
pandemic could be related to treatment modality (e.g. pa-
tients who were more affected were also more likely to
stay at home and receive telepsychiatric care) and at the
same time be associated with the outcome variables (e.g.
patients who are more affected by the pandemic may feel
more unwell, which may affect how they experience their
therapy sessions). Finally, level of functioning could also
be related to both treatment modality and our outcome
variables. However, for none of these variables did we ob-
serve statistically significant differences between groups.
Still, the findings of the present study are limited to situa-
tions in which patients (1) are already under treatment
and familiar with their therapist, and (2) have a say in the
choice of adjustment that is made in order to continue
treatment during a situation such as the COVID-19 pan-
demic. It is likely that many patients requested a setting
they thought they would feel comfortable with or suited
them for one reason or another. Although this does not
rule out that patients face difficulties with the modality
they requested (e.g. problems with focusing during a tele-
psychiatric session), it is conceivable that patients who did
not have a say in the first place may find it comparably
more difficult to adapt to their new setting. While the sub-
samples were too small to examine this possibility further,
descriptively, the telepsychiatric patients who had not re-
quested their modality were the only subgroup in which
the majority of patients indicated that the pre-COVID-19
sessions were better than the current sessions. Thus, fu-
ture research should further explore the role of choice in
the patients’ acceptance of and experience with telepsy-
chiatric treatment. Nonetheless, the circumstances in the
study at hand reflect a real-life situation and our study
provides valuable insights into how certain treatment op-
tions compare and what may need to be considered when
deciding on which adjustments should be made.
The fact that all patients were treated by one of two
therapists also limits the generalisability of the results.
Future research using a broader sample of therapists will
be needed to check the replicability of the results. More-
over, while the present study provides insight into the
vital question of whether interim telepsychiatric treat-
ment might affect TA differently from a face-to-face ses-
sion with the therapist wearing a face mask, future
studies should establish a baseline TA (i.e. TA during
therapy sessions without any adjustments) to investigate
how individual adjustments affect TA. In addition, the
impact of a prolonged use of certain adjustments or mo-
dalities on patient and therapist experience remains
unclear.
Finally, because of the small number of cases in the
video-conferencing group, the groups were collapsed for
the main analyses. While descriptive data in many cases
did not suggest major differences between the telephone
and the videoconferencing group for most variables,
future studies should aim to include large samples to
increase power to detect differences both between a
face-to-face and a telepsychiatry group and also between
different types of telepsychiatric settings. Our sensitivity
analyses suggested that further examining TA may be of
particular interest. The small number of cases was also
the reason to not correct for multiple testing within the
framework of this preliminary study.
Implications for practice and conclusion
Continuing psychiatric or psychotherapeutic treatment
during the COVID-19 pandemic required significant
changes to the way therapy sessions were conducted.
First findings on the impact of such adjustments re-
ported in the study at hand are encouraging; both op-
tions – on-site with the therapist wearing a mask and
telepsychiatry – seem viable alternatives for continuing
therapies during a situation such as the COVID-19 pan-
demic. Although telepsychiatric sessions were experi-
enced as less deep by the participants, no differences
were observed in post-session positivity, and the differ-
ence concerning depth might decline over time, espe-
cially in the videoconferencing condition. Also, no
differences in terms of client satisfaction or TA as per-
ceived by both patient and therapist were observed.
While the majority of patients would prefer an on-site
solution that does not involve the therapist wearing a
face mask, patients’ comments on the on-site session fo-
cused more on positive elements such as being able to
attend the session/speak to their therapist rather than
on issues related to the therapist wearing a face mask.
Therapists seemed to be more concerned about potential
negative impacts of the masks, and a similar observation
was made regarding the lack of visual cues in telephone
sessions.
When deciding on the modality or adjustment for a
specific session, our findings suggest that it may be
worthwhile for clinicians to consider the following two
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questions in addition to feasibility and patient prefer-
ence: First, is the topic of the session highly personal in
nature? If so, it might be worth discussing with the pa-
tient whether they would feel more comfortable with a
face-to-face session. Conversely, if the topic is more gen-
eral in nature (e.g. discussing medication), a telepsychia-
tric solution could be considered. Second, does the
session contain therapeutic elements, such as drawing
up plans and using whiteboards, that may be difficult or
impossible to implement in a telepsychiatric setting and
would not having access to these elements be particu-
larly detrimental to the session (aims)? This is particu-
larly relevant to sessions over the phone; advances in
technology may make this question obsolete if videocon-
ferencing is used and both parties are technically suffi-
ciently skilled. Finally, some patients mentioned a lack of
(physical and/or temporal) distance to their everyday life
if the session was off-site. It may therefore be helpful to
advise patients to take a short break (e.g. from working
from home) prior to their telepsychiatric appointment or
go to a specific location (e.g. separate room or place)
when participating in a therapy session.
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